Abstract:In the past century, noncommunicable diseases have surpassed infectious diseases as the principal cause of sickness and death, worldwide. Trillions of commensal microbes live in and on our body, and constitute the human microbiome. The vast majority of these microorganisms are maternally derived and live in the gut, where they perform functions essential to our health and survival, including: digesting food, activating certain drugs, producing short-chain fatty acids (which help to modulate gene expression by inhibiting the deacetylation of histone proteins), generating anti-inflammatory substances, and playing a fundamental role in the induction, training, and function of our immune system. Among the many roles the microbiome ultimately plays, it mitigates against untoward effects from our exposure to the environment by forming a biotic shield between us and the outside world. The importance of physical activity coupled with a balanced and healthy diet in the maintenance of our well-being has been recognized since antiquity. However, it is only recently that characterization of the host-microbiome intermetabolic and crosstalk pathways has come to the forefront in studying therapeutic design. As reviewed in this report, synthetic biology shows potential in developing microorganisms for correcting pathogenic dysbiosis (gut microbiota-host maladaptation), although this has yet to be proven. However, the development and use of small molecule drugs have a long and successful history in the clinic, with small molecule histone deacetylase inhibitors representing one relevant example already approved to treat cancer and other disorders. Moreover, preclinical research suggests that epigenetic treatment of neurological conditions holds significant promise. With the mouth being an extension of the digestive tract, it presents a readily accessible diagnostic site for the early detection of potential unhealthy pathogens resident in the gut. Taken together, the data outlined herein provide an encouraging roadmap toward important new medicines and companion diagnostic platforms in a wide range of therapeutic indications.

Effect of gut microbiota-derived metabolites and extracellular vesicles on neurodegenerative disease in a gut-brain axis chip

Crosstalk Between the Gut Microbiota and the Brain: an Update on Neuroimaging Findings

Mechanisms by which microbiome-derived metabolites exert their impacts on neurodegeneration

Microbiota-derived metabolites as drivers of gut–brain communication

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights

Effect of gut microbiome-derived metabolites and extracellular vesicles on hepatocyte functions in a gut-liver axis chip

Gut Metabolites Acting on the Gut-Brain Axis: Regulating the Functional State of Microglia

Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases

Gut microbiota-derived metabolites and their importance in neurological disorders

Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome

Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration

Organ-On-A-Chip in vitro Models of the Brain and the Blood-Brain Barrier and Their Value to Study the Microbiota-Gut-Brain Axis in Neurodegeneration

Gut Microbiota Interaction with the Central Nervous System throughout Life

The Progress of Gut Microbiome Research Related to Brain Disorders

Impact of gut-brain interaction in emerging neurological disorders

Gut microbes influence the development of central nervous system disorders through epigenetic inheritance

Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome?

Microbiota and Neurological Disorders: A Gut Feeling